Sichenzia Ross Ference LLP Represents Genetic Technologies Limited in $8 Million Public Offering

By Sichenzia Ross Ference LLP | May 28, 2020

Press Release – New York, NY – May 28, 2020 – Sichenzia Ross Ference LLP today announced that it represented Genetic Technologies Limited (NASDAQ: GENE), a leader in the development of genetic risk assessment tests, in a public offering of 4,000,000 American Depositary Shares (ADSs), each representing six hundred of the Company’s ordinary shares, at a purchase price of $2.00 per ADS.

The Sichenzia Ross Ference LLP team was led by partners Darrin Ocasio and Avital Perlman, counsel Jeffrey Cahlon, and associate Yian Pan.

Posted in News, Press Releases, Transactions and tagged american depository shares, Genetic Technologies Limited, Securities Law, securities law firm, transactions-prior